Formidable Asset Management LLC Acquires New Holdings in Intuitive Surgical, Inc. $ISRG

Formidable Asset Management LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,417 shares of the medical equipment provider’s stock, valued at approximately $961,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Parallel Advisors LLC boosted its stake in Intuitive Surgical by 0.7% during the third quarter. Parallel Advisors LLC now owns 40,866 shares of the medical equipment provider’s stock valued at $16,617,000 after buying an additional 285 shares during the period. Abacus Wealth Partners LLC bought a new position in shares of Intuitive Surgical in the third quarter worth approximately $247,000. United Advisor Group LLC raised its stake in Intuitive Surgical by 38.6% in the third quarter. United Advisor Group LLC now owns 3,670 shares of the medical equipment provider’s stock valued at $1,492,000 after purchasing an additional 1,022 shares in the last quarter. Plancorp LLC purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $502,000. Finally, May Hill Capital LLC bought a new stake in Intuitive Surgical during the third quarter valued at approximately $300,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Raymond James Financial reissued an “outperform” rating and issued a $480.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Barclays restated an “overweight” rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, August 14th. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a report on Wednesday, October 21st. Finally, Mizuho reduced their price objective on Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $493.54.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $452.80 on Monday. The company has a 50-day simple moving average of $409.93 and a two-hundred day simple moving average of $431.89. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a market cap of $156.96 billion, a price-to-earnings ratio of 54.75, a PEG ratio of 3.12 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the previous year, the business earned $2.40 earnings per share. The company’s quarterly revenue was up 21.7% on a year-over-year basis. Equities analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Mark Brosius sold 77 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the sale, the executive vice president owned 881 shares of the company’s stock, valued at approximately $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig H. Barratt sold 1,150 shares of the firm’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $510,370.00. Following the completion of the transaction, the director owned 1,150 shares in the company, valued at $510,370. This represents a 50.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 49,128 shares of company stock worth $21,614,167 over the last quarter. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile